Danta M[au] - Search Results

Year	Number of Results
1990	1
2002	1
2004	2
2005	3
2007	3
2008	3
2009	1
2010	3
2011	3
2012	2
2013	2
2014	6
2015	2
2016	3
2017	5
2018	5
2019	8
2020	8
2021	8
2022	3

1

The Role of Diet in the Pathogenesis and Management of Inflammatory Bowel Disease: A Review.

Wark G, Samocha-Bonet D, Ghaly S, Danta M. Wark G, et al. Among authors: danta m. Nutrients. 2020 Dec 31;13(1):135. doi: 10.3390/nu13010135. Nutrients. 2020. PMID: 33396537 Free PMC article. Review.

2

Dealing with the spiralling price of medicines: issues and solutions.

Ma CKK, Danta M, Day R, Ma DDF. Ma CKK, et al. Among authors: danta m. Intern Med J. 2018 Jan;48(1):16-24. doi: 10.1111/imj.13652. Intern Med J. 2018. PMID: 29068529 Review.

3

Transmission of HCV in HIV-positive populations.

Danta M, Rodger AJ. Danta M, et al. Curr Opin HIV AIDS. 2011 Nov;6(6):451-8. doi: 10.1097/COH.0b013e32834b4974. Curr Opin HIV AIDS. 2011. PMID: 22001890 Review.

4

Editorial: aspirin and NSAID for chemoprevention of hepatocellular carcinoma - ready for their use? Authors' reply.

Danta M, Tan RZH, Lockart I, Abdel Shaheed C. Danta M, et al. Aliment Pharmacol Ther. 2021 Sep;54(6):852-853. doi: 10.1111/apt.16568. Aliment Pharmacol Ther. 2021. PMID: 34425011 No abstract available.

5

Metabolic dysfunction-associated fatty liver disease and insulin resistance in type 1 diabetes.

Snaith JR, Danta M, Greenfield JR. Snaith JR, et al. Among authors: danta m. Lancet Gastroenterol Hepatol. 2021 Dec;6(12):985-986. doi: 10.1016/S2468-1253(21)00343-5. Lancet Gastroenterol Hepatol. 2021. PMID: 34774157 No abstract available.

6

All-cause hepatocellular carcinoma survival in the era of direct-acting antiviral therapy.

Lockart I, Hajarizadeh B, Buckley N, Davison S, Prakoso E, Levy MT, George J, Dore GJ, Danta M. Lockart I, et al. Among authors: danta m. J Gastroenterol Hepatol. 2021 Dec;36(12):3515-3523. doi: 10.1111/jgh.15687. Epub 2021 Sep 30. J Gastroenterol Hepatol. 2021. PMID: 34520088

7

Sexually transmitted hepatitis C infection: the new epidemic in MSM?

Bradshaw D, Matthews G, Danta M. Bradshaw D, et al. Among authors: danta m. Curr Opin Infect Dis. 2013 Feb;26(1):66-72. doi: 10.1097/QCO.0b013e32835c2120. Curr Opin Infect Dis. 2013. PMID: 23242342 Review.

8

Hepatitis C virus cure before hepatocellular carcinoma diagnosis is associated with improved survival.

Lockart I, Hajarizadeh B, Alavi M, Davison S, Prakoso E, Levy MT, George J, Dore GJ, Danta M. Lockart I, et al. Among authors: danta m. J Viral Hepat. 2021 May;28(5):710-718. doi: 10.1111/jvh.13475. Epub 2021 Feb 2. J Viral Hepat. 2021. PMID: 33481322

9

Preservation of Gastrointestinal Mucosal Barrier Function and Microbiome in Patients With Controlled HIV Infection.

Mak G, Zaunders JJ, Bailey M, Seddiki N, Rogers G, Leong L, Phan TG, Kelleher AD, Koelsch KK, Boyd MA, Danta M. Mak G, et al. Among authors: danta m. Front Immunol. 2021 May 31;12:688886. doi: 10.3389/fimmu.2021.688886. eCollection 2021. Front Immunol. 2021. PMID: 34135912 Free PMC article.

10

Sexually transmitted hepatitis C infection: the evolving epidemic in HIV-positive and HIV-negative MSM.

Lockart I, Matthews GV, Danta M. Lockart I, et al. Among authors: danta m. Curr Opin Infect Dis. 2019 Feb;32(1):31-37. doi: 10.1097/QCO.0000000000000515. Curr Opin Infect Dis. 2019. PMID: 30531370 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results